Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization

References

• BAKER, R. W., 1987, Controlled Release of Biological Active Agents (New York: John Wiley & Sons, Inc.), pp. 87–91.
   Google Scholar
• B REM, H., M AHALEY, M. S., V ICK, N. A., BLACK, K. L., S CHOLD, S. C., BURGER, P. C., FRIEDMAN A. H CITRIC, I. S., E LLER, T. W CCEZENS, J. W., and KENEALY, J. N., 1991, Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. Journal of Neurosurgery, 74, 441–446.
   Google Scholar
• B REM, H., PIANTADOSI, S., BURGER, P. C., WALKER, M., S ELKER, R., V ICK, N. A., BLACK, K., S ISTI, M., B REM, S., M OHR, G., M ULLER, P., M CRAWETZ, R., and S cHoup, S. C., 1995, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Lancet, 345, 1008–1012.
   PubMedGoogle Scholar
• DEwAAL, W. A. J., M AESSEN, F. J. M. J., and K RAAK, J. C., 1990, Analytical methodologies for the quantification of platinum anti-cancer drugs and related compounds in biological media. Journal of Pharmaceutical and Biomedical Analysis, 8, 1–30.
   Google Scholar
• GROSSMAN, S. A., R EINHARD, C., C OLVIN, M., C HASIN, M., B RUNDRETT, R., T AMARGQ R. J., and B REM, H., 1992, The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. Journal of Neurosurgery, 76, 640–647.
   Google Scholar
• HILL, B. T., W HELAN, R. D. H., and H CSKING, L. K., 1988, Use of human neuroblastoma contiguous cell lines for in vitro drug sensitivity screening. Investigational New Drugs, 6, 11.
   Google Scholar
• H OCHBERG, F. H., PRUITT, A. A., BECK, D. 0., D EB RUM, G., and DAVIS, K., 1985, The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma Journal of Neurosurgery, 63, 876–880.
   Google Scholar
• H ORA, M. S R ANA, R. K N UMBERG, J. H TICE T. R GILLEY, R. M., and HUDSON, M. E., 1990, Release of human serum albumin from poly(lactide-co-glycolide) micro-spheres. Pharmaceutical Research, 7, 1190–1194.
   Google Scholar
• JEFFERY, H., DAVIS, S. S., and 0' H AGAN, D. T., 1991, The preparation and characterization of poly(lasctide-co-glycolide) microspheres I: oil-in-water emulsion solvent evaporation. International Journal of Pharmaceutics, 77, 169–175.
   Google Scholar
• JUDY, K. D., OLIVI, A., B UAHIN, K. G D OMB, A., EPSTEIN, J. I., COLVIN, 0. M., and BREA H., 1995, Effectiveness of controlled release of a cyclophoshamide derivative with polymers against rat gliomas. Journal of Neurosurgery, 82, 481–486.
   Google Scholar
• KIM T. S H ALLIDAY, A. L., H EDLEY-WHYTE, E. T., and C GNVERY, K., 1991, Correlates of survival and the Daumas-Duport grading system for astrocytomas. Journal of Neurosurgery, 74, 27–37.
   Google Scholar
• KOU, J. H., EMMETT, C., SHEN, P. A SWANI, S I WAMOTQ T V AGHE, F., and SANDERS, L 1995, Brain biocompatibility of poly (D,L-lactic acid-co-Glycolic acid) implants. Pharmaceutical Research, 12, S–194.
   Google Scholar
• KULKARNI, R. K., M OORE, E. G., H EGYELI, A. F., and LEONARD, F., 1971, Biodegradable poly(lactic acid)polymers. Journal of Biomedical Materials Research, 5, 169–181.
   Google Scholar
• M AHALEY, M. S. JR., M ETTLIN, C., NATARJAN, N., LAWS, E. R. JR., and PEACE, B. B., 1989, National survey on patterns of care for brain tumor patients. Neurosurgery, 71, 826–836.
   Google Scholar
• M ENE', P., D ANEIL, V., M ONTRRO-M ENEI, C., B ROUILLARD, M POUPLARD- BARTHELADC, A., and BENOIT, J. P., 1993, Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. B iomaterials, 14, 470–478.
   Google Scholar
• Ruiz, J. M., B USNEL, J. P., and BENOIT, J. P., 1990, Influence of average molecular weights of p oly(D, L-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Pharmaceutical Research, 7, 928–934.
   PubMedGoogle Scholar
• Ruiz, J. M., TISSIER, B., and BENOIT, J. P., 1989, Microencapsulation of 10 peptides: a study of the phase separation of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil. International Journal of Pharmaceutics, 49, 69–77.
   Google Scholar
• S Alm, P., GREENSPAN, P., and Lu, D. R., 1997, Adsorption of brain proteins on the surface of poly(D, L- lactid e- co- glyc olide) (PL GA) microspheres. Drug Delivery, 4, 129–134.
   Google Scholar
• SHAH, S. S., CHA, Y., and PITT, C. G., 1992, Poly(glycolic acid-co-DL-lactic acid): diffusion or degradation controlled drug delivery? Journal of Controlled Release, 18, 261–270
   Google Scholar
• Sitti, E. P., TYLER, B PIANTADOSI, S BURGER, P. C., and B REM H., 1997, Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemotherapy and Pharmacology, 39, 383–389.
   Google Scholar
• T AMARGQ R. J., MYSEROS, J. S EPSTEIN, J. I YANG, M. B. CHASIN, M., and B REM, H., 1993, Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Research, 53, 329–333.
   PubMedGoogle Scholar
• T sm, T., MEHrA, R., and DELUCA, P., 1996, Adsorption of peptides to poly(D.L-lactide-co-glycolide). I. Effect of physical factors on the adsortion. International Journal of Pharmaceutics, 127, 31–42.
   Google Scholar
• US P DI, Drug Information for the Health Care Professional, 1996, (Rochville, MD: The United States Pharmacopeial Convention, Inc.), pp. 753–756.
   Google Scholar
• WALTER, K. A., CAHAN, M. A., GuR, A., TYLER, B H ILTGN, J., BURGER, P. C., D OMB, A., and B REM, H., 1994, Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Research, 54, 2207–2212.
   Google Scholar
• WATTS, P. J., DAVIS, M. C., and MELIA, C. D., 1990, Microencapsulation using emulsification-solvent evaporation an overview of techniques and application. Critical Reviews in Therapeutic Drug Carrier Systems, 7, 235–259.
   PubMedGoogle Scholar
• WEINGART, J. D., T HOMPSON, R. C., TYLER, B C OLVIN, 0. M., and B REM, H., 1995, Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intercranial 9L gliosarcoma model. International Journal of Cancer, 62, 605–609.
   Google Scholar